DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Craig-Hallum Initiates Coverage On Soleno Therapeutics with Buy Rating, Announces $8 Price Target

Craig-Hallum initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Buy rating and a $8 price target.

Benzinga · 01/10/2020 15:15

Craig-Hallum initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Buy rating and a $8 price target.